BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Höpfner M, Schuppan D, Scherübl H. Treatment of gastrointestinal neuroendocrine tumors with inhibitors of growth factor receptors and their signaling pathways: Recent advances and future perspectives. World J Gastroenterol 2008; 14(16): 2461-2473 [PMID: 18442192 DOI: 10.3748/wjg.14.2461]
URL: https://www.wjgnet.com/1007-9327/full/v14/i16/2461.htm
Number Citing Articles
1
Nicola Fazio, Saverio Cinieri, Katia Lorizzo, Michela Squadroni, Laura Orlando, Francesca Spada, Evaristo Maiello, Lisa Bodei, Giovanni Paganelli, Gianfranco Delle Fave, Filippo de Braud. Biological targeted therapies in patients with advanced enteropancreatic neuroendocrine carcinomasCancer Treatment Reviews 2010; 36: S87 doi: 10.1016/S0305-7372(10)70026-8
2
Alessia Di Florio, Veronica Sancho, Paola Moreno, Gianfranco Delle Fave, Robert T. Jensen. Gastrointestinal hormones stimulate growth of Foregut Neuroendocrine Tumors by transactivating the EGF receptorBiochimica et Biophysica Acta (BBA) - Molecular Cell Research 2013; 1833(3): 573 doi: 10.1016/j.bbamcr.2012.11.021
3
Sashikanta Swain, Ravi Kant Narayan, Pravash Ranjan Mishra. Unraveling the interplay: exploring signaling pathways in pancreatic cancer in the context of pancreatic embryogenesisFrontiers in Cell and Developmental Biology 2024; 12 doi: 10.3389/fcell.2024.1461278
4
Conor J. Shields, Emmanuel Tiret, Desmond C. Winter. Carcinoid Tumors of the RectumAnnals of Surgery 2010; 252(5): 750 doi: 10.1097/SLA.0b013e3181fb8df6
5
Katsunobu SAKURAI, Tadashi TSUKAMOTO, Sadatoshi SHIMIZU, Akishige KANAZAWA, Yoshito YAMASHITA, Yukio NISHIGUCHI. A CASE OF NEUROENDOCRINE CARCINOMA ORIGINATING FROM THE PAPILLA VATER OF THE DUODENUMNihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association) 2010; 71(3): 712 doi: 10.3919/jjsa.71.712
6
Giovanni Vitale, Silvia Carra, Francesco Ferraù, Elia Guadagno, Antongiulio Faggiano, Annamaria Colao. Gastroenteropancreatic neuroendocrine neoplasms and inflammation: A complex cross-talk with relevant clinical implicationsCritical Reviews in Oncology/Hematology 2020; 146: 102840 doi: 10.1016/j.critrevonc.2019.102840
7
Simona Falletta, Stefano Partelli, Corrado Rubini, Dominik Nann, Andrea Doria, Ilaria Marinoni, Vanessa Polenta, Carmelina Di Pasquale, Ettore degli Uberti, Aurel Perren, Massimo Falconi, Maria Chiara Zatelli. mTOR inhibitors response and mTOR pathway in pancreatic neuroendocrine tumorsEndocrine-Related Cancer 2016; 23(11): 883 doi: 10.1530/ERC-16-0329
8
Christophe Couderc, Gilles Poncet, Karine Villaume, Martine Blanc, Nicolas Gadot, Thomas Walter, Florian Lepinasse, Valérie Hervieu, Martine Cordier-Bussat, Jean-Yves Scoazec, Colette Roche. Targeting the PI3K/mTOR Pathway in Murine Endocrine Cell LinesThe American Journal of Pathology 2011; 178(1): 336 doi: 10.1016/j.ajpath.2010.11.023
9
Nupur K. Purohit, Rashmi G. Shah, Samuel Adant, Michael Hoepfner, Girish M. Shah, Jean-Mathieu Beauregard. Potentiation of 177Lu-octreotate peptide receptor radionuclide therapy of human neuroendocrine tumor cells by PARP inhibitorOncotarget 2018; 9(37): 24693 doi: 10.18632/oncotarget.25266
10
Elizabeth Batcher, Paul Madaj, Andrew G. Gianoukakis. Pancreatic Neuroendocrine TumorsEndocrine Research 2011; 36(1): 35 doi: 10.3109/07435800.2010.525085
11
Current World LiteratureCurrent Opinion in Endocrinology, Diabetes & Obesity 2009; 16(4): 328 doi: 10.1097/MED.0b013e32832eb365
12
Emilio Bajetta, Giuseppe Procopio, Sara Pusceddu, Filippo Pietrantonio, Massimo Milione, Marco Maccauro, Elena Verzoni, Valentina Guadalupi, Marco Platania. From biology to clinical experience: evolution in the knowledge of neuroendocrine tumoursOncology Reviews 2009; 3(2): 79 doi: 10.1007/s12156-009-0011-x
13
Hisato IGARASHI, Ken KAWABE, Tetsuhide ITO. Diagnosis and medical management of pancreatic endocrine tumor: InsulinomaSuizo 2008; 23(6): 676 doi: 10.2958/suizo.23.676
14
Verena Schenk, Elisabeth Rossegger, Clemens Ebner, Florian Bangerl, Klaus Reichmann, Björn Hoffmann, Michael Höpfner, Frank Wiesbrock. RGD-Functionalization of Poly(2-oxazoline)-Based Networks for Enhanced Adhesion to Cancer CellsPolymers 2014; 6(2): 264 doi: 10.3390/polym6020264
15
Michelle Kang Kim, Fei Ye, Daguang Wang, Miao Cui, Stephen C. Ward, Richard R.P. Warner, Sasan Roayaie, Michail Shafir, Myron Schwartz, David Zhang, Steven Itzkowitz. Differential Protein Expression in Small Intestinal Neuroendocrine Tumors and Liver MetastasesPancreas 2016; 45(4): 528 doi: 10.1097/MPA.0000000000000459